Zebra Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,382
| Closed | -$80K | – | 86 |
|
|
2022
Q2 | $80K | Sell |
11,382
-263
| -2% | -$1.85K | 0.24% | 91 |
|
|
2022
Q1 | $97K | Sell |
11,645
-5,848
| -33% | -$48.7K | 0.22% | 110 |
|
|
2021
Q4 | $118K | Sell |
17,493
-6,449
| -27% | -$43.5K | 0.19% | 141 |
|
|
2021
Q3 | $127K | Sell |
23,942
-23,152
| -49% | -$123K | 0.15% | 167 |
|
|
2021
Q2 | $271K | Sell |
47,094
-5,087
| -10% | -$29.3K | 0.32% | 114 |
|
|
2021
Q1 | $241K | Buy |
+52,181
| New | +$241K | 0.27% | 126 |
|
|
2020
Q3 | – | Sell |
-44,664
| Closed | -$206K | – | 180 |
|
|
2020
Q2 | $206K | Sell |
44,664
-1,010
| -2% | -$4.66K | 0.3% | 157 |
|
|
2020
Q1 | $176K | Sell |
45,674
-368
| -0.8% | -$1.42K | 0.28% | 155 |
|
|
2019
Q4 | $173K | Buy |
+46,042
| New | +$173K | 0.15% | 241 |
|